Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Open-label Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults

NCT05121506 is registered in ClinicalTrials.gov with Gefion Canada Inc. as lead sponsor.

NCT NCT05121506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05121506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Open-label Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
Lead sponsor
Gefion Canada Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 27, 2021
Completion date
January 18, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biological availability, cbd, skin absorption, thc